Regeneron will acquire 23andMe’s core assets for $256 million, ensuring customer data privacy and continuing the mission of ...

Recapping some of the most talked-about news this week from the nation and around the world – in case you missed it.

Alert: Your DNA Is At Risk in This New Age of Increased Surveillance** The recent sale of the genetic data company 23andMe to Regeneron Pharmaceuticals has raised significant concerns about the ...

Regeneron Pharmaceuticals has announced plans to acquire the genetic testing company 23andMe for $256 million, with a clear ...

Regeneron (REGN) announced initial results from two cohorts of the Phase 1b LINKER-MM2 trial evaluating linvoseltamab in combination with two different proteasome inhibitors – carfilzomib or ...

Successful trial results in the next few years could save thousands of lives and generate billions in new annual revenue for ...

Some public libraries have yearbooks from the schools that used to serve their towns. The Hoyt Memorial Library in Kingston ...